Elevance Health, Inc. (ELV) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Elevance Health, Inc. (ELV): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 52/100 — a percentile rank of Elevance Health, Inc.’s fundamentals against Finance & Real Estate peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $82.8B |
| P / E | 16.7× |
| P / S | 0.4× |
| EV / EBITDA | 11.8× |
| Gross margin | 26.0% |
| Operating margin | 3.6% |
| Net margin | 2.5% |
| Return on equity | 11.1% |
| ROIC | 9.4% |
| Revenue growth | 6.3% |
| Debt / equity | 0.7× |
| Dividend yield | 1.8% |
Is Elevance Health, Inc. overvalued? P/E looks fair vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from Elevance Health, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact